Steroid Therapy in Pneumonia Treatment

This chapter explores the efficacy and safety of steroid therapy for community-acquired pneumonia, particularly post-COVID vaccine rollout. It reviews a meta-analysis of studies showing a 3% improvement in all-cause mortality with corticosteroids, emphasizing their benefits in severe pneumonia cases. The discussion also highlights the importance of research rigor, clinical practices, and health economics in optimizing treatment strategies.